A.M. Crawford

1.2k total citations
13 papers, 974 citations indexed

About

A.M. Crawford is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, A.M. Crawford has authored 13 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 3 papers in Pharmacology and 2 papers in Biological Psychiatry. Recurrent topics in A.M. Crawford's work include Schizophrenia research and treatment (11 papers), Electroconvulsive Therapy Studies (4 papers) and Bipolar Disorder and Treatment (4 papers). A.M. Crawford is often cited by papers focused on Schizophrenia research and treatment (11 papers), Electroconvulsive Therapy Studies (4 papers) and Bipolar Disorder and Treatment (4 papers). A.M. Crawford collaborates with scholars based in United States, Australia and Spain. A.M. Crawford's co-authors include Charles M. Beasley, Gary D. Tollefson, Mary Anne Dellva, J. N. Beuzen, Pierre V. Trân, S.H. Hamilton, Olivier Blin, Harold J. Burstein, Annick D. Van den Abbeele and Steven E. Come and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Schizophrenia Research.

In The Last Decade

A.M. Crawford

13 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.M. Crawford United States	9	537	314	253	127	111	13	974
A. Steingart Canada	13	557 1.0×	108 0.3×	215 0.8×	109 0.9×	22 0.2×	15	1.2k
Paul H. Berg United States	15	486 0.9×	32 0.1×	51 0.2×	100 0.8×	67 0.6×	30	1.1k
L.S. Miller United States	11	219 0.4×	288 0.9×	15 0.1×	44 0.3×	42 0.4×	14	1.2k
Masayuki Takase Japan	14	374 0.7×	17 0.1×	95 0.4×	75 0.6×	71 0.6×	23	1.1k
Anna‐Greta Nylander Denmark	17	374 0.7×	58 0.2×	23 0.1×	55 0.4×	106 1.0×	33	905
Luigi Giorgi United Kingdom	18	852 1.6×	136 0.4×	105 0.4×	110 0.9×	3 0.0×	35	1.6k
Enrico D’Ambrosio Italy	16	236 0.4×	61 0.2×	23 0.1×	74 0.6×	36 0.3×	38	746
Kevin M. Bellew United States	13	148 0.3×	153 0.5×	77 0.3×	176 1.4×	5 0.0×	27	892
René Swanink United States	12	839 1.6×	35 0.1×	14 0.1×	552 4.3×	32 0.3×	20	1.3k
Marie‐Louise Holm Denmark	13	117 0.2×	50 0.2×	21 0.1×	32 0.3×	41 0.4×	27	800

Countries citing papers authored by A.M. Crawford

Since Specialization

Citations

This map shows the geographic impact of A.M. Crawford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Crawford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Crawford more than expected).

Fields of papers citing papers by A.M. Crawford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Crawford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Crawford. The network helps show where A.M. Crawford may publish in the future.

Co-authorship network of co-authors of A.M. Crawford

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Crawford. A scholar is included among the top collaborators of A.M. Crawford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Crawford. A.M. Crawford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lin, Nancy U., Lisa A. Carey, Minetta C. Liu, et al.. (2008). Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer. Journal of Clinical Oncology. 26(12). 1993–1999. 354 indexed citations

Gureje, Oye, Nicholas A Keks, David Grainger, et al.. (2003). Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophrenia Research. 61(2-3). 303–314. 70 indexed citations

Gómez, Juan Carlos & A.M. Crawford. (2001). Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.. PubMed. 62 Suppl 2. 6–11. 20 indexed citations

Basson, Bruce R., et al.. (2001). Weight change and atypical antipsychotic treatment in patients with schizophrenia.. PubMed. 62 Suppl 2. 41–4. 77 indexed citations

Lecrubier, Y., et al.. (1999). Olanzapine versus amisulpride and placebo in the treatment of negative symptoms and deficit states of chronic schizophrenia. European Neuropsychopharmacology. 9. 288–288. 13 indexed citations

David, S.R., A.M. Crawford, & Alan Breier. (1998). Prolactin levels in olanzapine versus typical and atypical antipsychotics. European Neuropsychopharmacology. 8. S229–S229. 8 indexed citations

David, S.R., A.M. Crawford, & Alan Breier. (1998). Prolactin levels in olanzapine versus typical and atypical antipsychotics. Schizophrenia Research. 29(1-2). 153–153. 8 indexed citations

Tran, P.V., Miro Jakovljević, G.D. Tollefson, et al.. (1998). 363. Olanzapine vs fluphenazine: Treatment of acute schizophrenic symptomatology and anxiety. Biological Psychiatry. 43(8). S109–S109. 7 indexed citations

Beasley, Charles M., S.H. Hamilton, A.M. Crawford, et al.. (1997). Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. European Neuropsychopharmacology. 7(2). 125–137. 245 indexed citations

10.

Crawford, A.M., Charles M. Beasley, & Gary D. Tollefson. (1997). The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophrenia Research. 26(1). 41–54. 152 indexed citations

11.

Crawford, A.M., Juan Carlos Gómez, Charles M. Beasley, & G.D. Tollefson. (1997). P.2.015 Olanzapine versus haloperidol: Analysis of schizophrenic patients from the multi-center international trial. European Neuropsychopharmacology. 7. S199–S199. 8 indexed citations

12.

Crawford, A.M., Charles M. Beasley, & G.D. Tollefson. (1997). P.2.016 The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentration. European Neuropsychopharmacology. 7. S199–S199. 4 indexed citations

13.

Tran, P., Charles M. Beasley, G.D. Tollefson, et al.. (1996). Acute and long-term results of the dose ranging double-blind olanzapine trial. European Neuropsychopharmacology. 6. 58–59. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact